What We’re Seeing

• Healthtech's export ambition: Inocras, Mediqstar, and DASON are all pursuing international expansion or FDA/CE pathways—evidence that Korea's healthtech sector now views regulatory approval in major markets as a primary milestone, not an afterthought.
• Bass Ventures backs early AI infrastructure: Bass Ventures backed both BioNexus (AI scientist agents) and ElevTalk (voice interfaces for non-native speakers) this week, clearly building a thesis around vertical AI tools that serve non-English-speaking or specialized knowledge workers.
• TIPS as a signal, not just capital: Superdisco and DASON both announced TIPS selection alongside or in lieu of private funding. For many startups, government program acceptance now carries reputational weight that can unlock follow-on private capital or corporate partnerships.
• Agent infrastructure is the new frontier: The global briefs are dominated by agent-production platforms (Sapiom, Naïve, Agency/Klaviyo). Korean startups in BioNexus and Comfo Labs are positioning in the same space—building platforms that let agents autonomously complete complex, multi-step workflows.
• Capital is concentrating in climate-tech hardware: Woori Technology's $27.5 million convertible and global mega-rounds for Base Power, Valar Atomics, and EON underscore a macro shift: infrastructure and energy hardware are attracting growth-stage capital at a pace that rivals software.